If you’ve ever looked up the Pfizer stock price, you know that the company is a large, well-known name in the pharmaceutical and biotechnology industry. The company has its headquarters on 42nd Street in Manhattan, and was founded in 1849 by two German entrepreneurs. Charles Pfizer and his cousin Charles F. Erhart created the company in order to make life better for themselves and their families.
You can invest in Pfizer stock by opening an account with a broker. The process is simple and takes less than 15 minutes. After that, you can place stock orders directly through your broker’s website. This makes buying Pfizer stock very similar to buying any other stock. Moreover, you can use your brokerage account to trade in other companies.
Pfizer is a major global pharmaceutical firm with annual sales close to $50 billion. Its product lines include vaccines and prescription drugs. Popular brands include Ibrance (a cancer treatment), Eliquis (a cardiovascular medication), and Xeljanz (an immunology drug). Pfizer sells its products worldwide, with international sales accounting for nearly half of total sales. Its earnings per share (EPS) for the trailing twelve months is 5.14 USD.
The company was founded in 1849 and is headquartered in New York. It also has research facilities in Japan, Australia, and Latin America. Pfizer’s portfolio includes a variety of medicines and vaccines, and it conducts clinical trials worldwide.